Consequently, depletion of TUG1 inhibited cell growth (Fig. 6d) and increased apoptosis, as evidenced by the Annexin V assay in cancer cells after treatment with TUG1 ASO for 48 h (Fig. 6e). Here, ANXA5 is linked to cancer.